Our research focuses on the cell and molecular biology of skeletal tissues in health and disease. We have strong interests in the characterisation of heterogeneous bone marrow mesenchymal stromal cells (MSCs), stem cell fate and the control of differentiation, tissue remodelling and regeneration. Our goal is to exploit our understanding of MSC biology and their secreted products, including extracellular vesicles (EVs), to develop new treatments for degenerative and inflammatory disorders.

​

We have established our company, Mesenbio, to help accelerate the translation of our research to patients.